Monday, 6 May, 2024
HomeRegulation

Regulation

New UK rules for treatment with acne drug

Britain’s health watchdog, the Medicines and Healthcare Products Regulatory Agency (MHRA), has announced a series of regulatory changes to strengthen the safe use of...

Suncreens containing toxins still available on shelves despite warnings

Despite warnings and safely concerns expressed by the US Food and Drug Administration (FDA) four years ago about dangerous ingredients in sunscreens, some of...

FDA approves Japan’s Alzheimer’s agitation drug

The first approved drug for agitation in Alzheimer’s patients has been approved by the US Food and Drug Administration, with Otsuka Pharmaceuticals’ brexpiprazole being...

Self-harm risk high immediately after starting antidepressants – US analysis

Patients who take antidepressants are at highest risk of self-harm in the weeks immediately after the drug is prescribed, an analysis of more than...

New, stricter rules for food labelling

Major changes are in store for how food items are labelled in South Africa, with the Department of Health having gazetted proposed recommendations in...

Why Africa urgently needs a continental medicines regulator

In most African countries, regulatory failures are a result of long-standing, well-recognised challenges facing individual medicines regulatory agencies across the continent. The limitations may be...